Power Law company profile

iTeos Therapeutics

Biotech & Life Sciences · Charleroi, Belgium · Founded 2011 · IPO 2020 Thoroughbred

Drug discovery company focused on tumour and cancer treatments

Revenue

$35M

Latest reported FY

Featured in $10B+ revenueThoroughbred · Power Law outcome

Investors

16 investors on iTeos Therapeutics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 4 investors entered at this stage

FundPlus

Hunza Ventures

SFPIM

Wallonie Entreprendre

Series B+ 12 investors entered at this stage

RTW Investments

Tavistock Group

Invus

UCLouvain

WE Venture

6 Dimensions Capital

Vives Partners

MPM BioImpact

Boxer Capital

HBM Partners

Curative Ventures

RA Capital Management

Global footprint

Where iTeos Therapeutics has talent and traffic

AI talent share

2.7% of workforce is AI talent
(1 of 37 staff)

Core AI00%

Other AI12.7%

Non-AI workforce3697.3%

Workforce by country

8 countries with
team presence

🇧🇪 Belgium65.9%

🇺🇸 United States21.7%

🇫🇷 France5.4%

🇬🇧 United Kingdom3.8%

🇪🇸 Spain0.8%

Top 5 of 8 shown

Web traffic by country

1K monthly visits
across markets

🇺🇸 United States50%

Top 1 markets shown

Market sentiment

What the market is saying about iTeos Therapeutics

An AI-synthesized read of the highest-engagement posts about iTeos Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See iTeos Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles